Nvidia and Intuitive Surgical: Competitive Landscape in Tech and Healthcare
Nvidia (NASDAQ: NVDA) is leading the artificial intelligence (AI) revolution, currently boasting a price-to-earnings (P/E) ratio of 31x. In comparison, Intuitive Surgical (NASDAQ: ISRG), a leader in surgical robotics, has a significantly higher P/E ratio of 50x but is considered relatively cheap based on its five-year average of 70%. The healthcare company’s revenue from surgical robot sales only constitutes 25% of its income, with services and accessories providing consistent annuity-like revenue streams.
In the first quarter of 2026, the number of surgeries performed using Intuitive Surgical’s da Vinci system saw a 17% year-over-year increase, while the number of da Vinci robots globally increased by only 12%. Intuitive Surgical’s growth potential may be further enhanced by the recent FDA clearance of its da Vinci Single Port surgical system for additional procedures, including inguinal hernia repairs and appendectomies.
As technology evolves rapidly, Nvidia faces stiff competition, while Intuitive Surgical’s products are less susceptible to obsolescence due to the long-term nature of medical equipment. Investors are weighing these dynamics as they consider potential growth opportunities in both companies.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
